Elisa Sozzi

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen

High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias

Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

Functional Classification and Experimental Dissection of Long Noncoding RNAs

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management

p53-dependent non-coding RNA networks in chronic lymphocytic leukemia

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients

Long Noncoding RNA and Cancer: A New Paradigm

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

Somatic Hypermutations Confer Rheumatoid Factor Activity in Hepatitis C Virus–Associated Mixed Cryoglobulinemia

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL

The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

The normal IGHV1-69–derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL

Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation